arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

PAVmed Inc.

PAVM
$4.74 ▼ -0.04 (-0.84%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
45 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Neutral
auto_awesome

Analytical Summary

PAVmed Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $7.5M
Dividend Yield
Revenue Growth 175.0%
Op. Margin
ROIC -20.3%
FCF / Share $-1.67
Trailing P/E
Price / Book 0.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

45-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$22.00K
↑ +175.0%
Net Income Profit after all expenses
$-60.00K
↑ +95.2%
FCF / Share Free cash flow per share
$-1.67
↓ -1361.3%

Health Breakdown

Returns
46
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 45 quarters